Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weightChristine M. Mack, David G. Parkes, Michael R. Hanley et al.|International Journal of Obesity|2009Cited by 112
Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weightChristine M. Mack, David G. Parkes, Julie Wilson et al.|American Journal of Physiology-Regulatory, Integrative and Comparative Physiology|2007Cited by 109
Combination Therapy with Amylin and Peptide YY[3–36] in Obese Rodents: Anorexigenic Synergy and Weight Loss AdditivityJonathan D. Roth, David G. Parkes, Todd Coffey et al.|Endocrinology|2007Cited by 77
Enhanced Amylin-Mediated Body Weight Loss in Estradiol-Deficient Diet-Induced Obese RatsJames L. Trevaskis, Jonathan D. Roth, Victoria F. Turek et al.|Endocrinology|2010Cited by 60
Antiobesity effects of the β-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese ratsJonathan D. Roth, David G. Parkes, James L. Trevaskis et al.|International Journal of Obesity|2008Cited by 43